| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 03/16/2010 | US7680601 Generating antibiotic; transforming cell with expression vector coding polyketide synthase; computational analysis of polyketides and computer-assisted design of PKS genes are facilitated by representing structure of polyketide and/or PKS gene that encodes PKS that produces polyketide |
| 03/16/2010 | US7678928 Hypocholesteremic drug; high purity and substantially free of impurities through a step of isolation and crystallization |
| 03/16/2010 | US7678927 phase transfer catalysts; industrial scale |
| 03/11/2010 | WO2010027418A1 Photochromic 2h-chr0menes annelated at c5-c6 and their methods of preparation |
| 03/11/2010 | WO2009148282A3 Novel diaryl hepatonoid compound and use thereof |
| 03/11/2010 | US20100059710 Novel pyran derivative, its preparation method, liquid crystal composition and liquid crystal display device comprising the same |
| 03/10/2010 | CN101665478A Isoaloeresin D and separation and extraction method for aloin |
| 03/09/2010 | US7674823 DNA-PK inhibitors |
| 03/09/2010 | US7674807 N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-methanesulfonyloxy-phthalamic acid; 3-fluoro-N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid; effect against harmful insects without giving phytotoxicity on cultured plants |
| 03/09/2010 | CA2482346C Substituted phenylacetamides and their use as glucokinase activators |
| 03/03/2010 | EP1753858B1 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 03/03/2010 | CN100593033C Liquid-crystalline compounds having a tetrahydropyran ring |
| 02/25/2010 | WO2010022313A2 Processes for the preparation of sglt2 inhibitors |
| 02/25/2010 | US20100048690 Antitumoral dihydropyran-2-one compounds |
| 02/25/2010 | CA2734295A1 Processes for the preparation of sglt2 inhibitors |
| 02/24/2010 | EP2157086A1 Method for producing glycoside aglycone |
| 02/24/2010 | EP2155680A1 Indanone derivatives that inhibit prolyl hydroxylase |
| 02/24/2010 | EP1729775B1 Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin |
| 02/24/2010 | EP1458675B1 Alpha-cyanoacrylates |
| 02/24/2010 | EP1458674B1 Beta-amino-alpha-cyanoacrylates and their use as herbicides |
| 02/24/2010 | CN100591676C 2- and 2,5-substituted phenylketo-enols |
| 02/23/2010 | US7666861 Cytoskeletal active compounds, composition and use |
| 02/23/2010 | US7666619 Compounds and methods for regulating bacterial growth and pathogenesis |
| 02/18/2010 | WO2009106552A3 Contrast agents |
| 02/18/2010 | US20100041656 Novel amide derivatives and medicinal use thereof |
| 02/18/2010 | US20100038588 Liquid Crystal Compound Having Lactone Ring, Liquid Crystal Composition, And Liquid Crystal Display Device |
| 02/17/2010 | EP2152265A1 New method for preparing isofagomine and its derivatives |
| 02/16/2010 | CA2442882C Sulphones which modulate the action of gamma-secretase |
| 02/11/2010 | US20100035865 Sulfonamides and Pharmaceutical Compositions Thereof |
| 02/10/2010 | EP2150620A2 Method for preparing c-6 phosphorylated d-aldohexoses and c-6 phosphorylated d-aldohexose derivatives, and new c-6 phosphorylated d-aldohexose derivatives |
| 02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/09/2010 | US7659307 Heterocyclic carboxamides and their use as fungicides |
| 02/09/2010 | CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 02/02/2010 | US7655808 Leptomycin B; antiproliferative agents; antitumor agents; antcarcinogenic agents; inhibiting the export of a protein from the nucleus of a cell via a CRM1-mediated process; tissue-targeted therapy; cancer of human breast, lung, ovaries, prostate, and bladder, and leukemia cell |
| 02/02/2010 | US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 02/02/2010 | US7655666 Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands |
| 02/02/2010 | CA2434162C Reaction method utilizing diaphram type catalyst and apparatus therefor |
| 01/28/2010 | WO2010010578A2 A key intermediate for the preparation of stilbenes |
| 01/28/2010 | US20100022788 Microwave Integrated Soxhlet |
| 01/28/2010 | US20100021847 Oxime Compound and Resist Composition Containing the Same |
| 01/27/2010 | EP2146952A1 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 01/26/2010 | US7652031 Compounds which mimic the chemical and biological properties of discodermolide |
| 01/26/2010 | US7651742 Liquid-crystalline medium and liquid-crystal display comprising 1,2-difluoroethene compounds |
| 01/21/2010 | WO2010007027A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 01/21/2010 | US20100016532 such as 1,1,2,3,3-pentafluoro-4-alkoxycarbonyl-1,6-heptadiene; addition polymerization; improved transparency and durable light resistance, and water and oil repellency |
| 01/21/2010 | US20100016422 Solid forms of (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol and methods of their use |
| 01/21/2010 | US20100016249 Cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof |
| 01/21/2010 | US20100014010 Formulations comprising mesogen containing compounds |
| 01/21/2010 | CA2730734A1 Deuterated benzylbenzene derivatives and methods of use |
| 01/21/2010 | CA2730708A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 01/20/2010 | EP1915387B1 Novel glucopyranose esters and glucofuranose esters of alkyl- fumarates and their pharmaceutical use |
| 01/20/2010 | CN101628905A C-aryl glucoside SGLT2 inhibitors and method |
| 01/20/2010 | CN100582101C Antitumoral agent |
| 01/19/2010 | US7649016 Comprising 1,5-D-anhydrofructose and/or ascopyrone; medicine has effects of ascopyrone in inhibiting the growth and metastasis of tumors, is expected to inhibit inflammation, and exerts an excellent effect on prognosis |
| 01/19/2010 | US7649014 Inhibit uncoupling protein-2 (UCP2); treating deficient first-phase insulin secretion, non-insulin dependent diabetes mellitus, and ischemia |
| 01/19/2010 | US7649005 Substituted benzylaminoalkylene heterocycles |
| 01/14/2010 | WO2009132453A8 Cyclylamine derivatives as calcium channel blockers |
| 01/13/2010 | EP2143719A1 Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity |
| 01/13/2010 | CN100579973C Process for producing glucal |
| 01/12/2010 | CA2560489C Pyranone compounds useful to treat retroviral infections |
| 01/12/2010 | CA2407838C Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/07/2010 | WO2010001821A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative and use of the pharmaceutical composition |
| 01/07/2010 | WO2010000773A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides |
| 01/07/2010 | WO2009124723A3 Novel aureothin derivatives |
| 01/07/2010 | US20100004472 Biosurfactant-containing skin care cosmetic and skin roughness-improving agent |
| 01/07/2010 | US20100004469 Antimicrobial agents and microbicidal agents |
| 01/07/2010 | CA2729724A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides |
| 01/07/2010 | CA2729405A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 01/06/2010 | CN101619053A Preparation method of Delta-lactone |
| 01/05/2010 | US7642367 Diamino-functional chalcones |
| 01/05/2010 | US7642363 Chemical intermediates providing simple route for preparation of HMG CoA reductase inhibitors; crystalline, high purity; precursors for statins |
| 01/05/2010 | US7642285 Compounds and methods for modulating communication and virulence in quorum sensing bacteria |
| 01/05/2010 | US7642284 Luminacin analogs and uses thereof |
| 01/05/2010 | CA2545999C 1,2-di(cyclic)substituted benzene compounds |
| 01/05/2010 | CA2428255C Onium salts and the use therof as latent acids |
| 12/31/2009 | US20090326215 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 12/31/2009 | US20090326186 Mesogen containing compounds |
| 12/31/2009 | US20090323011 Mesogen containing compounds |
| 12/30/2009 | WO2009158381A1 Novel psymberin derivatives, compositions, and their use as antineoplastic agents |
| 12/30/2009 | WO2009157313A1 Liquid crystalline compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display element |
| 12/30/2009 | WO2009156889A1 Diaryl compounds and uses thereof |
| 12/30/2009 | EP2136800A1 Modulation of bacterial quorum sensing with synthetic ligands |
| 12/30/2009 | CA2727573A1 Diaryl compounds and uses thereof |
| 12/29/2009 | US7638641 Tetrahydropyran derivatives |
| 12/24/2009 | US20090318714 Organic compounds |
| 12/24/2009 | US20090318713 Process for manufacturing a cyclic diester of an a-hydroxy acid |
| 12/24/2009 | US20090318481 Potentiators Of Glutamate Receptors |
| 12/23/2009 | WO2009154766A1 Renin inhibitors and method of use thereof |
| 12/23/2009 | WO2009092702A3 ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate and process for the production employing a 2-deoxyribose-5-phosphate aldolase |
| 12/23/2009 | EP2134696A2 Processes for the preparation of statins, particularly rosuvastatin, and intermediates for the preparation thereof |
| 12/23/2009 | EP2134688A1 Fluorinated derivatives of deferiprone |
| 12/23/2009 | EP1888552B1 CRYSTALLINE FORM OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
| 12/23/2009 | CN101607952A Preparation method of D-gluconic acid-delta-lactone |
| 12/23/2009 | CA2727987A1 Renin inhibitors and method of use thereof |
| 12/22/2009 | US7635741 Curable polyacetylenes used as dielectrics in making microelectronics such as integrated circuits |
| 12/17/2009 | WO2009150095A1 Pesticidal compositions containing a pyrandione or a thiopyrandione or a cyclohexanetrione derivative |
| 12/17/2009 | WO2009150094A1 Novel herbicides |
| 12/17/2009 | WO2009150093A1 Novel herbicides |
| 12/17/2009 | US20090312555 Process and intermediate compounds useful in the preparation of statins |
| 12/16/2009 | EP2133345A1 Process for the manufacture of epoxybutanol intermediates |